Patents by Inventor Heiko Tietgen

Heiko Tietgen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bengamide derivatives, process for preparing them, and their use
    Patent number: 7534591
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: May 19, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Heiko Tietgen
  • BENGAMIDE DERIVATIVES, PROCESS FOR PREPARING THEM, AND THEIR USE
    Publication number: 20070065929
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: November 2, 2006
    Publication date: March 22, 2007
    Applicant: Sanofi-aventis Deutschland GmbH
    Inventors: Holger HOFFMANN, Sabine HAAG-RICHTER, Michael KURZ, Heiko TIETGEN
  • BENGAMIDE DERIVATIVES, PROCESS FOR PREPARING THEM, AND THEIR USE
    Publication number: 20070065932
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: November 2, 2006
    Publication date: March 22, 2007
    Applicant: Sanofi-aventis Deutschland GmbH
    Inventors: Holger HOFFMANN, Sabine HAAG-RICHTER, Michael Kurz, Heiko Tietgen
  • Bengamide derivatives, process for preparing them, and their use
    Patent number: 7153846
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898)
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: December 26, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Michael Kurz, Heiko Tietgen
  • Bengamide derivatives, process for preparing them, and their use
    Publication number: 20050171089
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: October 22, 2004
    Publication date: August 4, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Michael Kurz, Heiko Tietgen